Market Access
5 Essential Steps to Address Access Barriers Beyond Coverage
For years, payer strategies in the U.S. have had just one goal in mind: ...
How COVID-19 Has Changed the Way We Reach Payers
We still don’t know how COVID-19 will affect us over time, but details are ...
Into the Mind of the Payer
Payers (Aetna, BCBS, Humana, etc.) are very aware of the power they hold over ...
How Do You Define Value in Healthcare?
One the biggest questions in the cancer care ecosystem is: When can we expect ...
How Will Politics, Economic Stress, COVID, and More Change the Payer Landscape?
To help get at the heart of how the events of the past year ...
Successfully Navigating the Long Road to Medical Device Reimbursement
The Road to Hana is a 64-mile stretch of highway connecting Kahului to the ...
Three Areas Payers Are Redefining Following COVID
The pandemic has altered every facet of our healthcare system, so the payer landscape ...
Two Key Questions About Payer Strategies in 2021
PM360 asked experts in market access and working with payers what innovations to expect ...
Biden Takes Bold Steps to Reverse Years of Healthcare Disparities
We can’t ignore the lessons of the COVID-19 crisis: our healthcare and public health ...
2021: A “Tale of Two Cities” for the Pharma Industry
Uncertainty was the prevailing theme of 2020 across nearly every sector and business function ...
What You Need to Know About the Trump Administration’s Final Rule on Transparency in Coverage
In a continued push for increasing price transparency in healthcare, the Trump administration recently ...
340B Cuts Could Impact Access to Specialty Drugs
For more than 25 years, the 340B Drug Pricing Program1 has helped safety-net facilities ...
Can “Risk-Sharing” Agreements Enable Fast Access to COVID-19 Vaccines?
As the global COVID-19 pandemic has progressed, so too have efforts to develop, manufacture, ...
